These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Oseltamivir: a review of its use in influenza. McClellan K; Perry CM Drugs; 2001; 61(2):263-83. PubMed ID: 11270942 [TBL] [Abstract][Full Text] [Related]
23. Clinical use of approved influenza antivirals: therapy and prophylaxis. Ison MG Influenza Other Respir Viruses; 2013 Jan; 7 Suppl 1(Suppl 1):7-13. PubMed ID: 23279892 [TBL] [Abstract][Full Text] [Related]
24. Optimizing antiviral therapy for influenza: understanding the evidence. Ison MG Expert Rev Anti Infect Ther; 2015 Apr; 13(4):417-25. PubMed ID: 25695406 [TBL] [Abstract][Full Text] [Related]
25. A new antiviral agent for influenza--is there a clinical niche? Couch RB N Engl J Med; 1997 Sep; 337(13):927-8. PubMed ID: 9302309 [No Abstract] [Full Text] [Related]
26. Measures for control of influenza. Couch RB Pharmacoeconomics; 1999; 16 Suppl 1():41-5. PubMed ID: 10623375 [TBL] [Abstract][Full Text] [Related]
27. Antivirals in the management of an influenza pandemic. Harrod ME; Emery S; Dwyer DE Med J Aust; 2006 Nov; 185(S10):S58-61. PubMed ID: 17115954 [TBL] [Abstract][Full Text] [Related]
28. Clinical Implications of Antiviral Resistance in Influenza. Li TC; Chan MC; Lee N Viruses; 2015 Sep; 7(9):4929-44. PubMed ID: 26389935 [TBL] [Abstract][Full Text] [Related]
29. Antiviral drugs for influenza for 2020-2021. Med Lett Drugs Ther; 2020 Nov; 62(1610):169-172. PubMed ID: 33429402 [No Abstract] [Full Text] [Related]
30. Perspectives on antiviral use during pandemic influenza. Hayden FG Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1877-84. PubMed ID: 11779387 [TBL] [Abstract][Full Text] [Related]
31. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons. Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968 [TBL] [Abstract][Full Text] [Related]
32. Antiviral therapy and prophylaxis for influenza in children. American Academy of Pediatrics Committee on Infectious Diseases Pediatrics; 2007 Apr; 119(4):852-60. PubMed ID: 17403862 [TBL] [Abstract][Full Text] [Related]
33. Neuraminidase inhibitor susceptibility profile of human influenza viruses during the 2016-2017 influenza season in Mainland China. Huang W; Cheng Y; Li X; Tan M; Wei H; Zhao X; Xiao N; Dong J; Wang D J Infect Chemother; 2018 Sep; 24(9):729-733. PubMed ID: 29866491 [TBL] [Abstract][Full Text] [Related]
34. Antiviral drugs for influenza. Med Lett Drugs Ther; 2012 Jan; 54(1381):1-3. PubMed ID: 22233587 [No Abstract] [Full Text] [Related]
36. Antivirals for influenza in healthy adults: systematic review. Jefferson T; Demicheli V; Rivetti D; Jones M; Di Pietrantonj C; Rivetti A Lancet; 2006 Jan; 367(9507):303-13. PubMed ID: 16443037 [TBL] [Abstract][Full Text] [Related]
39. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Jefferson T; Demicheli V; Deeks J; Rivetti D Cochrane Database Syst Rev; 2000; (2):CD001265. PubMed ID: 10796625 [TBL] [Abstract][Full Text] [Related]
40. Which agents should we use to treat and prevent influenza in 2006-2007? Mossad SB Cleve Clin J Med; 2006 Nov; 73(11):1016-8. PubMed ID: 17128543 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]